Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Cohen Fred E
Relationship:  
City:   San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   9    
Direct Shares   366,218    

Indirect Shares

   4,593,263      
Direct Value   $4,854,907    

Indirect Value

   $56,674,287      
Total Shares   4,959,481      
Total Value   $61,529,194      


Five Prime Therapeutics Inc $942,666 Biocryst Pharmaceuticals Inc $784,524 Caredx, Inc. $1,792,644 Intellia Therapeutics, Inc. $921,924 Urogen Pharma Ltd. $203,250 Veracyte, Inc. $209,900 Progyny, Inc. $0 Five Prime Therapeutics Inc $942,666 Biocryst Pharmaceuticals Inc $784,524 Caredx, Inc. $1,792,644 Intellia Therapeutics, Inc. $921,924 Urogen Pharma Ltd. $203,250 Veracyte, Inc. $209,900 Progyny, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    1    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   1.0   
     Percentage Gain/Loss :
     0.0%
 216.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Genomic Health Inc GHDX Director 2019-11-08 0 2019-11-08 0    Premium*  
            Five Prime Therapeutics Inc FPRX Director 2016-01-11 24,807 2014-07-01 0    Premium*  
            Biocryst Pharmaceuticals Inc BCRX Director 2017-09-18 119,410 2014-08-29 0    Premium*  
            Caredx, Inc. CDNA Director 2023-06-16 132,592 2014-10-01 0    Premium*  
            Intellia Therapeutics, Inc. NTLA Director 2023-06-14 41,716 2019-03-01 0    Premium*  
            Urogen Pharma Ltd. URGN Director 2019-02-06 15,000 2023-07-26 69,339    Premium*  
            Veracyte, Inc. VCYT Director 2020-10-19 10,000 2019-08-02 0    Premium*  
            Progyny, Inc. PGNY Director 2024-05-23 22,693 2020-10-24 0    Premium*  
            Kyverna Therapeutics KYTX 2024-02-12 0 2024-02-12 4,523,924    Premium*  
* Premium Members only  

Records found :    117         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2014-11-28 4 A $10.81 $8,745 D/D 809 1,457 0 -
CDNA Caredx, Inc. Director   –       •      –    2015-01-01 4 A $0.00 $0 D/D 1,143 1,801 0 -
GHDX Genomic Health Inc Director   –       •      –    2015-01-01 4 A $31.97 $9,975 D/D 312 62,683 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2015-01-08 4 OE $1.29 $129,000 D/D 100,000 101,457 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2015-02-27 4 A $10.20 $8,741 D/D 857 102,314 0 -
CDNA Caredx, Inc. Director   –       •      –    2015-04-01 4 A $0.00 $0 D/D 1,075 2,876 0 -
GHDX Genomic Health Inc Director   –       •      –    2015-04-01 4 A $30.43 $9,981 D/D 328 63,011 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2015-05-29 4 A $11.21 $8,744 D/D 780 103,094 0 -
GHDX Genomic Health Inc Director   –       •      –    2015-07-01 4 A $27.34 $9,979 D/D 365 63,376 0 -
CDNA Caredx, Inc. Director   –       •      –    2015-07-01 4 A $0.00 $0 D/D 1,227 4,103 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2015-08-31 4 A $11.64 $8,742 D/D 751 103,845 0 -
CDNA Caredx, Inc. Director   –       •      –    2015-10-01 4 A $0.00 $0 D/D 1,008 5,111 0 -
GHDX Genomic Health Inc Director   –       •      –    2015-10-01 4 A $21.34 $9,987 D/D 468 63,844 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2015-11-30 4 A $10.61 $8,743 D/D 824 104,669 0 -
CDNA Caredx, Inc. Director   –       •      –    2016-01-01 4 A $0.00 $0 D/D 1,836 6,947 0 -
GHDX Genomic Health Inc Director   –       •      –    2016-01-01 4 A $35.20 $9,997 D/D 284 64,128 0 -
FPRX Five Prime Therapeutics I... Director   –       •      –    2016-01-11 4 OE $5.54 $245,294 D/D 24,695 24,807 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2016-02-29 4 A $1.99 $8,748 D/D 4,396 109,065 0 -
CDNA Caredx, Inc. Director   –       •      –    2016-04-01 4 A $0.00 $0 D/D 1,954 8,901 0 -
GHDX Genomic Health Inc Director   –       •      –    2016-04-01 4 A $25.48 $9,988 D/D 392 64,520 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2016-05-31 4 A $3.39 $8,750 D/D 2,581 111,646 0 -
GHDX Genomic Health Inc Director   –       •      –    2016-07-01 4 A $26.74 $9,974 D/D 373 64,893 0 -
CDNA Caredx, Inc. Director   –       •      –    2016-07-01 4 A $0.00 $0 D/D 2,695 11,596 0 -
CDNA Caredx, Inc. Director   –       •      –    2016-07-15 4 A $0.00 $0 D/D 5,000 16,596 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2016-09-01 4 A $4.11 $10,000 D/D 2,433 114,079 0 -
  117  Records found
  1   2  3   4   5      
  Page 2 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us